36氪报道绿康生物IPO获批、股东减持及AI工具讨论

本文如何被排名

Signal score

0 / 100

Composite score across the factors below. Higher = stronger signal that this story matters right now.

Newsworthiness bucket

Research

该集群包含多条独立新闻，包括IPO批准、股东减持以及关于AI工具使用政策的讨论。[lever_c_demoted from significant: ic=1 ai=0.4]

Source corroboration

Single-source cluster

Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.

Topics

funding, product, policy

Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.

AI-industry relevance

Standard

On-topic for AI-industry coverage; kept in the public index.

Story freshness

133 days old

Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

完整方法见我们的编辑标准。